IBDEI046 ; ; 12-JAN-2012
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JAN 12, 2012
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5336,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5336,1,1,0)
 ;;=1^695.13
 ;;^UTILITY(U,$J,358.3,5336,1,2,0)
 ;;=2^STEVENS-JOHNSON SYNDROME
 ;;^UTILITY(U,$J,358.3,5336,2)
 ;;=^336636
 ;;^UTILITY(U,$J,358.3,5337,0)
 ;;=695.15^^50^369^6
 ;;^UTILITY(U,$J,358.3,5337,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5337,1,1,0)
 ;;=1^695.15
 ;;^UTILITY(U,$J,358.3,5337,1,2,0)
 ;;=2^TOXIC EPIDRML NECROLYSIS
 ;;^UTILITY(U,$J,358.3,5337,2)
 ;;=^336638
 ;;^UTILITY(U,$J,358.3,5338,0)
 ;;=695.9^^50^369^7
 ;;^UTILITY(U,$J,358.3,5338,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5338,1,1,0)
 ;;=1^695.9
 ;;^UTILITY(U,$J,358.3,5338,1,2,0)
 ;;=2^OTHER ERYTHEMATOUS SKIN COND
 ;;^UTILITY(U,$J,358.3,5338,2)
 ;;=^123902
 ;;^UTILITY(U,$J,358.3,5339,0)
 ;;=441.9^^50^370^1
 ;;^UTILITY(U,$J,358.3,5339,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5339,1,1,0)
 ;;=1^441.9
 ;;^UTILITY(U,$J,358.3,5339,1,2,0)
 ;;=2^ANEURYSM,AORTIC W/ DISSECTION
 ;;^UTILITY(U,$J,358.3,5339,2)
 ;;=^9277
 ;;^UTILITY(U,$J,358.3,5340,0)
 ;;=442.9^^50^370^2
 ;;^UTILITY(U,$J,358.3,5340,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5340,1,1,0)
 ;;=1^442.9
 ;;^UTILITY(U,$J,358.3,5340,1,2,0)
 ;;=2^ANEURYSM,NON-AORTIC
 ;;^UTILITY(U,$J,358.3,5340,2)
 ;;=^7390
 ;;^UTILITY(U,$J,358.3,5341,0)
 ;;=710.3^^50^370^3
 ;;^UTILITY(U,$J,358.3,5341,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5341,1,1,0)
 ;;=1^710.3
 ;;^UTILITY(U,$J,358.3,5341,1,2,0)
 ;;=2^DERMATOMYOSITIS
 ;;^UTILITY(U,$J,358.3,5341,2)
 ;;=^33162
 ;;^UTILITY(U,$J,358.3,5342,0)
 ;;=446.5^^50^370^4
 ;;^UTILITY(U,$J,358.3,5342,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5342,1,1,0)
 ;;=1^446.5
 ;;^UTILITY(U,$J,358.3,5342,1,2,0)
 ;;=2^GIANT CELL ARTERITIS
 ;;^UTILITY(U,$J,358.3,5342,2)
 ;;=^117658
 ;;^UTILITY(U,$J,358.3,5343,0)
 ;;=446.20^^50^370^5
 ;;^UTILITY(U,$J,358.3,5343,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5343,1,1,0)
 ;;=1^446.20
 ;;^UTILITY(U,$J,358.3,5343,1,2,0)
 ;;=2^HYPERSENSITIVITY ANGIITIS, UNS
 ;;^UTILITY(U,$J,358.3,5343,2)
 ;;=^60279
 ;;^UTILITY(U,$J,358.3,5344,0)
 ;;=446.3^^50^370^6
 ;;^UTILITY(U,$J,358.3,5344,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5344,1,1,0)
 ;;=1^446.3
 ;;^UTILITY(U,$J,358.3,5344,1,2,0)
 ;;=2^LETHAL MIDLINE GRANULOMA
 ;;^UTILITY(U,$J,358.3,5344,2)
 ;;=^52905
 ;;^UTILITY(U,$J,358.3,5345,0)
 ;;=446.1^^50^370^7
 ;;^UTILITY(U,$J,358.3,5345,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5345,1,1,0)
 ;;=1^446.1
 ;;^UTILITY(U,$J,358.3,5345,1,2,0)
 ;;=2^MUCOCUTANEOUS LYMPH SYND (MCLS)
 ;;^UTILITY(U,$J,358.3,5345,2)
 ;;=^79494
 ;;^UTILITY(U,$J,358.3,5346,0)
 ;;=443.9^^50^370^8
 ;;^UTILITY(U,$J,358.3,5346,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5346,1,1,0)
 ;;=1^443.9
 ;;^UTILITY(U,$J,358.3,5346,1,2,0)
 ;;=2^PERIPH VASCULAR DIS NOS
 ;;^UTILITY(U,$J,358.3,5346,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,5347,0)
 ;;=446.0^^50^370^9
 ;;^UTILITY(U,$J,358.3,5347,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5347,1,1,0)
 ;;=1^446.0
 ;;^UTILITY(U,$J,358.3,5347,1,2,0)
 ;;=2^POLYARTERITIS NODOSA
 ;;^UTILITY(U,$J,358.3,5347,2)
 ;;=^91874
 ;;^UTILITY(U,$J,358.3,5348,0)
 ;;=710.4^^50^370^10
 ;;^UTILITY(U,$J,358.3,5348,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5348,1,1,0)
 ;;=1^710.4
 ;;^UTILITY(U,$J,358.3,5348,1,2,0)
 ;;=2^POLYMYOSITIS
 ;;^UTILITY(U,$J,358.3,5348,2)
 ;;=^186822
 ;;^UTILITY(U,$J,358.3,5349,0)
 ;;=452.^^50^370^11
 ;;^UTILITY(U,$J,358.3,5349,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5349,1,1,0)
 ;;=1^452.
 ;;^UTILITY(U,$J,358.3,5349,1,2,0)
 ;;=2^PORTAL VEIN THROMBOSIS
 ;;^UTILITY(U,$J,358.3,5349,2)
 ;;=^269815
 ;;^UTILITY(U,$J,358.3,5350,0)
 ;;=714.2^^50^370^12
 ;;^UTILITY(U,$J,358.3,5350,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5350,1,1,0)
 ;;=1^714.2
 ;;^UTILITY(U,$J,358.3,5350,1,2,0)
 ;;=2^RHEUMATOID ARTHRITIS,SYSTEMIC
 ;;^UTILITY(U,$J,358.3,5350,2)
 ;;=^272111
 ;;^UTILITY(U,$J,358.3,5351,0)
 ;;=135.^^50^370^13
 ;;^UTILITY(U,$J,358.3,5351,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5351,1,1,0)
 ;;=1^135.
 ;;^UTILITY(U,$J,358.3,5351,1,2,0)
 ;;=2^SARCOIDOSIS
 ;;^UTILITY(U,$J,358.3,5351,2)
 ;;=^107916
 ;;^UTILITY(U,$J,358.3,5352,0)
 ;;=710.0^^50^370^14
 ;;^UTILITY(U,$J,358.3,5352,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5352,1,1,0)
 ;;=1^710.0
 ;;^UTILITY(U,$J,358.3,5352,1,2,0)
 ;;=2^SYST LUPUS ERYTHEMATOSIS
 ;;^UTILITY(U,$J,358.3,5352,2)
 ;;=^72159
 ;;^UTILITY(U,$J,358.3,5353,0)
 ;;=710.1^^50^370^15
 ;;^UTILITY(U,$J,358.3,5353,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5353,1,1,0)
 ;;=1^710.1
 ;;^UTILITY(U,$J,358.3,5353,1,2,0)
 ;;=2^SYSTEMIC SCLEROSIS
 ;;^UTILITY(U,$J,358.3,5353,2)
 ;;=^108590
 ;;^UTILITY(U,$J,358.3,5354,0)
 ;;=446.7^^50^370^16
 ;;^UTILITY(U,$J,358.3,5354,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5354,1,1,0)
 ;;=1^446.7
 ;;^UTILITY(U,$J,358.3,5354,1,2,0)
 ;;=2^TAKAYASU'S DISEASE
 ;;^UTILITY(U,$J,358.3,5354,2)
 ;;=^117141
 ;;^UTILITY(U,$J,358.3,5355,0)
 ;;=446.6^^50^370^17
 ;;^UTILITY(U,$J,358.3,5355,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5355,1,1,0)
 ;;=1^446.6
 ;;^UTILITY(U,$J,358.3,5355,1,2,0)
 ;;=2^THROMBOT MICROANGIOPATHY
 ;;^UTILITY(U,$J,358.3,5355,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,5356,0)
 ;;=446.4^^50^370^18
 ;;^UTILITY(U,$J,358.3,5356,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5356,1,1,0)
 ;;=1^446.4
 ;;^UTILITY(U,$J,358.3,5356,1,2,0)
 ;;=2^WEGENER'S GRANULOMATOSIS
 ;;^UTILITY(U,$J,358.3,5356,2)
 ;;=^127623
 ;;^UTILITY(U,$J,358.3,5357,0)
 ;;=444.9^^50^370^19
 ;;^UTILITY(U,$J,358.3,5357,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5357,1,1,0)
 ;;=1^444.9
 ;;^UTILITY(U,$J,358.3,5357,1,2,0)
 ;;=2^OTH ARTERIAL EMB/THROMBOSIS
 ;;^UTILITY(U,$J,358.3,5357,2)
 ;;=^39452
 ;;^UTILITY(U,$J,358.3,5358,0)
 ;;=710.9^^50^370^20
 ;;^UTILITY(U,$J,358.3,5358,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5358,1,1,0)
 ;;=1^710.9
 ;;^UTILITY(U,$J,358.3,5358,1,2,0)
 ;;=2^OTH CONNECTIVE TISSUE DISEASE
 ;;^UTILITY(U,$J,358.3,5358,2)
 ;;=^123811
 ;;^UTILITY(U,$J,358.3,5359,0)
 ;;=453.9^^50^370^21
 ;;^UTILITY(U,$J,358.3,5359,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5359,1,1,0)
 ;;=1^453.9
 ;;^UTILITY(U,$J,358.3,5359,1,2,0)
 ;;=2^OTH VENOUS EMB/THROMBOSIS
 ;;^UTILITY(U,$J,358.3,5359,2)
 ;;=^39455
 ;;^UTILITY(U,$J,358.3,5360,0)
 ;;=042.^^50^371^1
 ;;^UTILITY(U,$J,358.3,5360,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5360,1,1,0)
 ;;=1^042.
 ;;^UTILITY(U,$J,358.3,5360,1,2,0)
 ;;=2^AIDS OR HIV INFECTION
 ;;^UTILITY(U,$J,358.3,5360,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,5361,0)
 ;;=540.9^^50^371^2
 ;;^UTILITY(U,$J,358.3,5361,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5361,1,1,0)
 ;;=1^540.9
 ;;^UTILITY(U,$J,358.3,5361,1,2,0)
 ;;=2^APPENDICITIS
 ;;^UTILITY(U,$J,358.3,5361,2)
 ;;=^270195
 ;;^UTILITY(U,$J,358.3,5362,0)
 ;;=682.9^^50^371^3
 ;;^UTILITY(U,$J,358.3,5362,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5362,1,1,0)
 ;;=1^682.9
 ;;^UTILITY(U,$J,358.3,5362,1,2,0)
 ;;=2^CELLULITIS AND ABSCESS
 ;;^UTILITY(U,$J,358.3,5362,2)
 ;;=^21160
 ;;^UTILITY(U,$J,358.3,5363,0)
 ;;=576.1^^50^371^4
 ;;^UTILITY(U,$J,358.3,5363,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5363,1,1,0)
 ;;=1^576.1
 ;;^UTILITY(U,$J,358.3,5363,1,2,0)
 ;;=2^CHOLANGITIS
 ;;^UTILITY(U,$J,358.3,5363,2)
 ;;=^23291
 ;;^UTILITY(U,$J,358.3,5364,0)
 ;;=574.70^^50^371^5
 ;;^UTILITY(U,$J,358.3,5364,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5364,1,1,0)
 ;;=1^574.70
 ;;^UTILITY(U,$J,358.3,5364,1,2,0)
 ;;=2^CHOLECYSTITIS
 ;;^UTILITY(U,$J,358.3,5364,2)
 ;;=^304314
 ;;^UTILITY(U,$J,358.3,5365,0)
 ;;=571.5^^50^371^6
 ;;^UTILITY(U,$J,358.3,5365,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5365,1,1,0)
 ;;=1^571.5
 ;;^UTILITY(U,$J,358.3,5365,1,2,0)
 ;;=2^CIRRHOSIS,NON-ALCOHOLIC
 ;;^UTILITY(U,$J,358.3,5365,2)
 ;;=^24731
 ;;^UTILITY(U,$J,358.3,5366,0)
 ;;=323.9^^50^371^7
 ;;^UTILITY(U,$J,358.3,5366,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5366,1,1,0)
 ;;=1^323.9
 ;;^UTILITY(U,$J,358.3,5366,1,2,0)
 ;;=2^ENCEPHALITIS/MYELITIS
 ;;^UTILITY(U,$J,358.3,5366,2)
 ;;=^334231
 ;;^UTILITY(U,$J,358.3,5367,0)
 ;;=421.9^^50^371^8
 ;;^UTILITY(U,$J,358.3,5367,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5367,1,1,0)
 ;;=1^421.9
 ;;^UTILITY(U,$J,358.3,5367,1,2,0)
 ;;=2^ENDOCARDITIS
 ;;^UTILITY(U,$J,358.3,5367,2)
 ;;=^269701
 ;;^UTILITY(U,$J,358.3,5368,0)
 ;;=422.90^^50^371^9
 ;;^UTILITY(U,$J,358.3,5368,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5368,1,1,0)
 ;;=1^422.90
 ;;^UTILITY(U,$J,358.3,5368,1,2,0)
 ;;=2^MYOCARDITIS
 ;;^UTILITY(U,$J,358.3,5368,2)
 ;;=^269702
 ;;^UTILITY(U,$J,358.3,5369,0)
 ;;=728.86^^50^371^10
 ;;^UTILITY(U,$J,358.3,5369,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5369,1,1,0)
 ;;=1^728.86
 ;;^UTILITY(U,$J,358.3,5369,1,2,0)
 ;;=2^NECROTIZING FASCIITIS
 ;;^UTILITY(U,$J,358.3,5369,2)
 ;;=^303314
 ;;^UTILITY(U,$J,358.3,5370,0)
 ;;=730.20^^50^371^11
 ;;^UTILITY(U,$J,358.3,5370,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5370,1,1,0)
 ;;=1^730.20
 ;;^UTILITY(U,$J,358.3,5370,1,2,0)
 ;;=2^OSTEOMYELITIS NOS-UNSPEC
 ;;^UTILITY(U,$J,358.3,5370,2)
 ;;=^87108
 ;;^UTILITY(U,$J,358.3,5371,0)
 ;;=420.90^^50^371^12
 ;;^UTILITY(U,$J,358.3,5371,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5371,1,1,0)
 ;;=1^420.90
 ;;^UTILITY(U,$J,358.3,5371,1,2,0)
 ;;=2^PERICARDITIS
 ;;^UTILITY(U,$J,358.3,5371,2)
 ;;=^269692
 ;;^UTILITY(U,$J,358.3,5372,0)
 ;;=481.^^50^371^13
 ;;^UTILITY(U,$J,358.3,5372,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5372,1,1,0)
 ;;=1^481.
 ;;^UTILITY(U,$J,358.3,5372,1,2,0)
 ;;=2^PNEUMONIA,PNEUMOCOCCAL
 ;;^UTILITY(U,$J,358.3,5372,2)
 ;;=^95612
 ;;^UTILITY(U,$J,358.3,5373,0)
 ;;=480.0^^50^371^14
 ;;^UTILITY(U,$J,358.3,5373,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5373,1,1,0)
 ;;=1^480.0
 ;;^UTILITY(U,$J,358.3,5373,1,2,0)
 ;;=2^PNEUMONIA,VIRAL
 ;;^UTILITY(U,$J,358.3,5373,2)
 ;;=^269928
 ;;^UTILITY(U,$J,358.3,5374,0)
 ;;=486.^^50^371^15
 ;;^UTILITY(U,$J,358.3,5374,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5374,1,1,0)
 ;;=1^486.
 ;;^UTILITY(U,$J,358.3,5374,1,2,0)
 ;;=2^PNEUMONIA, ORGANISM NOS
